Dublin, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/q4697h/nuclear_medicine)
has announced the addition of the
"Nuclear Medicine - Global Strategic Business Report" report to
their offering.
This report analyzes the worldwide markets for Nuclear Medicine in
US$ Million by the following Product Segments: Gamma Cameras, and
PET Scanners. The report provides separate comprehensive analytics
for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2010
through 2018. A six-year historic analysis is also provided for
these markets.
The report profiles 43 companies including many key and niche players such as:
- Digirad Corporation
- GE Healthcare Plc
- Phillips Healthcare, Inc.
- Positron Corporation
- Siemens Medical Solutions USA, Inc.
- Toshiba Medical Systems Corporation
- Toshiba America Medical Systems, Inc.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations I-1
- Disclaimers I-2
- Data Interpretation & Reporting Level I-2
- Quantitative Techniques & Analytics I-3
- Product Definitions and Scope of Study I-3
- Gamma Cameras I-3
- PET Scanners I-4
II. Executive Summary
1. INDUSTRY OVERVIEW AND OUTLOOK II-1
- Market Snapshots II-1
- Nuclear Medicine - An Introduction II-1
- Market Witnesses Turbulent Times in Recent Past II-2
- Isotope Supply Shock - A Major Factor for Market Decline II-2
- Market Rebounds Brighter Prospects Ahead II-2
- Growth Drivers in a Nutshell II-3
- Current and Future Analysis II-3
- Emerging Markets to Drive Growth US Still in Spotlight II-4
- Susceptibility to Cardiac Disease, Brain Disorders and Cancers Influence Procedure Volumes II-4
- Minimal Impact of Recession on the Medical Contrast Media Market II-4
2. TRENDS AND ISSUES II-5
- Global Technetium Shortage Eased II-5
- Market Shifts to Hybrid Imaging II-5
- PET Eats its Way into Conventional Gamma Camera Market II-6
- PET-MRI Emerging as a Promising Standard for Imaging Soft Tissue Contrast II-6
- High Costs - A Major Threat for Market Growth II-6
- Technology Innovations Promise Bright Prospects II-7
- New Innovations in the Nuclear Medicine Device Market II-7
- SPECT/CT Scanners Drive Nuclear Medicine Equipment Market in North America II-7
- Global Nuclear Medicine Market - Historic Statistics II-8
3. COMPETITIVE LANDSCAPE II-9
- Competition Overview in Nuclear Medicine Market II-9
- Leading Players in the Worldwide Nuclear Medicine Market: A Completive Analysis II-11
4. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW II-12
- Medical Imaging Changing the Landscape of Clinical Diagnosis II-12
- Image-Guided Interventions - Driving Growth in Nuclear Medicine Arena II-12
- Understanding the Concept II-12
- Tremendous Market Potential II-12
- Clinical Application Areas II-12
- Diagnostic Imaging Witnesses Dramatic Growth II-13
- Comparison of Modalities, by Various Imaging Systems II-15
- Medical Imaging Equipment Manufacturers Fine Tune Technologies II-16
- Future Growth Prospects for Medical Imaging Equipment Market II-16
- Multiple Factors Support Global MRI Equipment Market Growth II-16
- Reimbursement Remains the Core Issue II-17
5. NUCLEAR MEDICINE - AN INSIGHT II-18
- Distinct from General Radiology II-18
- History II-18
- Major Developments II-19
- Nuclear Medicine Scans II-19
- Bone Scan II-20
- Brain Scan II-20
- Gallbladder Scan II-20
- Kidney Scan II-21
- Liver Scan II-21
- Lung Scan II-21
- Thyroid Scan II-21
- Scrotal Scan II-21
- Applications II-22
- Cardiac Applications II-22
- Neurologic Applications II-22
- Oncologic Applications II-22
- Orthopedic Applications II-22
- Pulmonary Applications II-23
- Renal Applications II-23
- Other Applications II-23
- Estimated Time Allocations for Nuclear Medicine Procedures II-24
- Radioisotopes: Essential for Nuclear Medicine Procedure II-24
- Radioisotopes Used in Medicine II-25
- Clinical Applications of Select Isotopes II-26
- Radionuclides in Nuclear Medicine Procedures II-27
- Positron-Emitting Radionuclides in PET Procedures II-28
6. NUCLEAR MEDICINE IMAGING EQUIPMENT II-29
- Gamma Cameras II-29
- Positron Emission Tomography (PET) Scanners II-29
- Factors Influencing Growth of PET Scanners II-30
- PET & Other Imaging Modalities II-30
- Brain Imaging II-32
- Alzheimer's Disease II-32
- Brain Trauma II-32
- Epilepsy II-32
- Heart Imaging II-32
- Mobile PET II-33
- Parkinson's Disease II-33
- PET & Cancer II-33
- PET-CT: An Advancement in Cancer Diagnosis & Treatment II-33
7. RESEARCH AND DEVELOPMENT II-34
- Researchers Develop Portable PET Scanner, SynchroPET II-34
- Philips and University Medical Center Hamburg- Eppendorf Develop MRI/PET Imaging Tool II-34
- Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-34
8. PRODUCT INNOVATIONS/INTRODUCTIONS II-35
- Siemens Healthcare to Unveil Biograph mCT 20 Excel, a PET CT Imager II-35
- MEDX Launches T-Quest™ Gamma Camera II-35
- Philips Electronics Introduces GEMINI LXL - A PET/CT Scanner II-35
- GE Healthcare Unveils PETtrace 880 - A High Capacity Cyclotron II-36
- Royal Philips Launches BrightView X - A Mid-level SPECT Camera II-36
- Philips Unveils GEMINI TF PET/CT for Oncology Applications II-36
- Siemens Introduces c.cam SPECT System II-36
- Positron Introduces PosiRx Solution II-37
- Naviscan Unveils High-resolution PET Scanner with PEM Biopsy Capability II-37
- Integrated Modular Systems Releases New Version of imsiPACS Server II-37
9. RECENT INDUSTRY ACTIVITY II-38
- BC Technical Acquires Xpert II-38
- GE Healthcare Acquires Orbotech Medical Solutions II-38
- Comecer Acquires Veenstra Instruments II-38
- Positron Secures Group Purchasing Agreement from Amerinet II-39
- GE Healthcare Collaborates with NXT2B II-39
- Zecotek Inks Development Deal with NuCare II-39
- Siemens Healthcare receives FDA Clearance for Biograph mCT PET CT Scanner II-40
- GE Healthcare Receives US FDA Clearance for Brivo NM615 Gamma Camera II-40
- Digirad Inks Deal with Dilon Diagnostics II-40
- Positron Obtains Approval for Marketing Attrius PET scanners in Canada II-41
- Royal Philips Electronics Receives US FDA 510(k) Clearance for Ingenuity TF PET/MR II-41
10. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-42
- Hybridyne Obtains FDA Clearance for ProxiScanTM Gamma Camera II-42
- Digirad Bags FDA Clearance for Portable Imaging System II-42
- Digirad Inks Asset Purchase Agreement with MD Office Solutions II-42
- Positron Inks Agency Agreement with TIS II-43
- Dilon Diagnostics Inks Agreement with Philips Healthcare II-43
11. FOCUS ON SELECT GLOBAL PLAYERS II-44
- Digirad Corporation (USA) II-44
- GE Healthcare Plc (The United Kingdom) II-44
- Phillips Healthcare, Inc. (USA) II-44
- Positron Corporation (USA) II-44
- Siemens Medical Solutions USA, Inc. (USA) II-45
- Toshiba Medical Systems Corporation (Japan) II-45
- Toshiba America Medical Systems, Inc. (USA) II-45
12. GLOBAL MARKET PERSPECTIVE II-46
III. Market
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD
IV. Competitive Landscape
Total Companies Profiled: 43 (including Divisions/Subsidiaries -
(54)
- The United States (34)
- Canada (1)
- Japan (5)
- Europe (8)
- - Germany (3)
- - The United Kingdom (1)
- - Italy (2)
- - Rest of Europe (2)
- Asia-Pacific (Excluding Japan) (5)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/q4697h/nuclear_medicine
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Pharmaceuticals